Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-02

Clinical Trial Update: GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial testing a GnRH agonist combined with hCG and hMG for treating men with non-obstructive azoospermia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonadotropin-releasing hormone agonist
  • Human chorionic gonadotropin (human chorionic gonadotropin)
  • Human menopausal gonadotropin (human menopausal gonadotropin)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Azoospermia | Phase 2 | Status: UNKNOWN